scholarly journals Increased Serum Levels of Growth-Related Oncogene-α in Patients with Generalized Pustular Psoriasis

Dermatology ◽  
2010 ◽  
Vol 220 (1) ◽  
pp. 46-48 ◽  
Author(s):  
Yasunobu Kato ◽  
Toshiyuki Yamamoto
2015 ◽  
Vol 7 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Chiharu Tominaga ◽  
Masaaki Yamamoto ◽  
Yasutomo Imai ◽  
Kiyofumi Yamanishi

A 78-year-old woman who had been suffering from psoriasis vulgaris for 31 years was admitted to hospital because of her erythroderma. A toxic eruption was suspected and she was treated with prednisolone 30 mg daily. However, it was ineffective and, suspecting psoriatic erythroderma, cyclosporine 150 mg daily was administered with tapering of the prednisolone. Two weeks after a dose reduction of cyclosporine to 100 mg/day, erythroderma with widespread generalized pustules and fever developed. Histology of a biopsy revealed inflammatory infiltrates in the skin with a spongiform pustule of Kogoj, which was consistent with generalized pustular psoriasis (GPP). Her pustules improved with additional etretinate 20 mg/day, but the erythroderma persisted and she consulted us. Three sessions of granulocyte and monocyte apheresis once weekly were effective for her condition and decreased her serum levels of IL-6 and IL-8. She had homozygous mutations of c.[28C>T] in IL36RN which cause p.[Arg10Ter]. She is the oldest reported case of GPP with a deficiency of interleukin-36 receptor antagonist (DITRA), although GPP in DITRA has been suggested to usually occur in younger cases with no pre-existing psoriasis vulgaris.


2020 ◽  
Vol 83 (6) ◽  
pp. AB137
Author(s):  
Yurika Kawasaki ◽  
Masahiro Kamata ◽  
Mayumi Nagata ◽  
Saki Fukaya ◽  
Kotaro Hayashi ◽  
...  

2013 ◽  
Vol 34 (3) ◽  
pp. 153-161 ◽  
Author(s):  
Masaaki Yamamoto ◽  
Yasutomo Imai ◽  
Yoshiko Sakaguchi ◽  
Takashi Haneda ◽  
Kiyofumi Yamanishi

To characterize serum biomarkers reflecting the severity of generalized pustular psoriasis (GPP), we measured multiple cytokine/chemokine levels in 39 serum samples from 6 cases with GPP during the course of the disease. Serum levels of IL-4, IL-8, CXCL1 and CCL3 were positively correlated with the severity scores of GPP, white blood cell counts and serum C-reactive protein levels. Serum levels of IL-1β, IL-1ra, IL-6, IL-10, IL-12p70, IL-18, IL-22, IFN-γand VEGF showed strong positive correlations (r> 0.4,p< 0.01) with all those 3 clinical markers. Of those, IL-10 and IL-22 were significantly decreased after treatment in parallel with the GPP score and therefore those two serum cytokines might be useful to evaluate the efficacy of treatment for GPP.


1979 ◽  
Vol 115 (10) ◽  
pp. 1215-1216 ◽  
Author(s):  
F. R. Murphy

1999 ◽  
Vol 61 (2) ◽  
pp. 144-147
Author(s):  
Miyako KUDO ◽  
Yoshihiro UMEBAYASHI ◽  
Tomoe KOTSUJI ◽  
Fujio OTSUKA

2013 ◽  
Vol 75 (6) ◽  
pp. 504-507
Author(s):  
Reiko TSUTSUMI ◽  
Koji ADACHI ◽  
Yuichi YOSHIDA ◽  
Osamu YAMAMOTO

2001 ◽  
Vol 63 (3) ◽  
pp. 248-251 ◽  
Author(s):  
Tomomi NAKATANI ◽  
Minoru TAKATA ◽  
Shigeru KAWARA ◽  
Kiyoshi UCHIDA

Sign in / Sign up

Export Citation Format

Share Document